Atogepant for the Preventive Treatment of Migraine in Participants With Prior Treatment Failure: The ELEVATE Trial

被引：0
|
作者：
Pozo-Rosich, P. [1 ]
Nagy, K. [2 ]
Tassorelli, C. [3 ,4 ]
Lanteri-Minet, M. [5 ]
Sacco, S. [6 ]
Nezadal, T. [7 ]
Finnegan, M. [8 ]
Guo, H. [8 ]
Gandhi, P. [8 ]
Trugman, J. [8 ]
机构：
[1] Vall DHebron Univ Hosp, Barcelona, Spain
[2] AbbVie, Budapest, Hungary
[3] C Mondino Fdn, Headache Sci & Neurorehabil Ctr, Pavia, Italy
[4] CHU Nice, Pain Dept, Nice, France
[5] CHU Nice, FHU InovPain, Nice, France
[6] Cote Azur Univ, Nice, France
[7] Charles Univ Prague, Mil Univ Hosp, Sch Med 1, Dept Neurol, Prague, Czech Republic
[8] AbbVie, Madison, NJ USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR-137
引用
收藏
页码：212 / 213
页数：2
相关论文
共 50 条
  • [1] Atogepant for the Preventive Treatment of Migraine Among Participants With Episodic Migraine With Prior Treatment Failure: Results From the ELEVATE Trial
    Pozo-Rosich, P.
    Nagy, K.
    Tassorelli, C.
    Lanteri-Minet, M.
    Sacco, S.
    Nezadal, T.
    Finnegan, M.
    Guo, H.
    Ferreira, De Abreu R.
    Trugman, J.
    HEADACHE, 2023, 63 : 117 - 117
  • [2] Atogepant for the Preventive Treatment of Migraine Among Participants With Episodic Migraine With Prior Treatment Failure: Results From the ELEVATE Trial
    Pozo-Rosich, Patricia
    Nagy, Krisztian
    Tassorelli, Cristina
    Lanteri-Minet, Michel
    Sacco, Sara
    Nezadal, Tomas
    Finnegan, Michelle
    Guo, Hua
    Ferreira, Rosa De Abreu
    Trugman, Joel M.
    CEPHALALGIA, 2023, 43 (1supp) : 47 - 49
  • [3] Response Rates With Oral Atogepant in Participants With Prior Preventive Treatment Failure: Results From ELEVATE
    Pozo-Rosich, P.
    Nagy, K.
    Tassorelli, C.
    Lanteri-Minet, M.
    Sacco, S.
    Nezadal, T.
    Finnegan, M.
    Luo, L.
    Gandhi, P.
    Trugman, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 213 - 214
  • [4] Response Rates With Oral Atogepant in Participants With Prior Preventive Treatment Failure: Results From ELEVATE
    Pozo-Rosich, Patricia
    Nagy, Krisztian
    Tassorelli, Cristina
    Lanteri-Minet, Michel
    Sacco, Sara
    Nezadal, Tomas
    Finnegan, Michelle
    Luo, Lei
    Gandhi, Pranav
    Trugman, Joel M.
    CEPHALALGIA, 2023, 43 (1supp) : 31 - 32
  • [5] Atogepant for the Preventive Treatment of Migraine
    Ailani, Jessica
    Lipton, Richard B.
    Goadsby, Peter J.
    Guo, Hua
    Miceli, Rosa
    Severt, Lawrence
    Finnegan, Michelle
    Trugman, Joel M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (08): : 695 - 706
  • [6] Sustained and Subsequent Response to Atogepant Among Individuals With Episodic Migraine With Prior Treatment Failure: Post Hoc Analysis of the ELEVATE Trial
    Sacco, Simona
    Nagy, Krisztian
    Chalermpalanupap, Natty
    Vernieri, Fabrizio
    Smith, Jonathan H.
    Holle-Lee, Dagny
    Liu, Yingyi
    Carr, Karen
    Pozo-Rosich, Patricia
    Lipton, Richard B.
    CEPHALALGIA, 2023, 43 (1supp) : 265 - 266
  • [7] Atogepant demonstrates early functional and quality of life improvements for the preventive treatment of episodic migraine after prior inadequate response to treatment: results from the ELEVATE trial
    Holle-Lee, D.
    Gandhi, P.
    Reuter, U.
    Ailani, J.
    Lipton, R. B.
    Nagy, K.
    Liu, Y.
    Carr, K.
    Stokes, J.
    Tassorelli, C.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [8] Safety and Tolerability of Ubrogepant for the Acute Treatment of Migraine in Participants Taking Atogepant for the Preventive Treatment of Episodic Migraine: Results from the TANDEM Trial
    Ailani, Jessica
    Lipton, Richard B.
    Blumenfeld, Andrew M.
    He, Molly Yizeng
    Smith, Jonathan H.
    Trugman, Joel M.
    Ferreira, Rosa de Abreu
    Brand-Schieber, Elimor
    CEPHALALGIA, 2023, 43 (1supp)
  • [9] Safety and tolerability of ubrogepant for the acute treatment of migraine in participants taking atogepant for the preventive treatment of episodic migraine: Results from the TANDEM study
    Ailani, Jessica
    Lipton, Richard B.
    Blumenfeld, Andrew M.
    Mechtler, Laszlo
    Klein, Brad C.
    He, Molly Yizeng
    Smith, Jonathan H.
    Trugman, Joel M.
    Ferreira, Rosa de Abreu
    Brand-Schieber, Elimor
    HEADACHE, 2024,
  • [10] Atogepant, the first oral preventive treatment for chronic migraine
    Haanes, Kristian A.
    Edvinsson, Lars
    LANCET, 2023, 402 (10404): : 748 - 749
12345